Thomas D. Reed, Chief Science Officer at INTREXON CORP (XON), sold 2,986 shares at $5.77 ($17K) on 2020-01-03, disclosed to the SEC on 2020-01-06.
Scheduled sale ($17k) by Chief Science Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XON | SELL | 2019-10-02 | $20K | — | Filing → |
| XON | SELL | 2019-07-02 | $27K | — | Filing → |
| XON | SELL | 2019-03-06 | $954K | — | Filing → |